  $\textbf{Purpose}$: To develop a clinical CEST MR fingerprinting (CEST-MRF)
method for brain tumor quantification using EPI acquisition and deep learning
reconstruction. $\textbf{Methods}$: A CEST-MRF pulse sequence originally
designed for animal imaging was modified to conform to hardware limits on
clinical scanners while keeping scan time $\leq$ 2 minutes. Quantitative MRF
reconstruction was performed using a deep reconstruction network (DRONE) to
yield the water relaxation and chemical exchange parameters. The feasibility of
the 6 parameter DRONE reconstruction was tested in simulations in a digital
brain phantom. A healthy subject was scanned with the CEST-MRF sequence,
conventional MRF and CEST sequences for comparison. Reproducibility was
assessed via test-retest experiments and the concordance correlation
coefficient (CCC) calculated for white matter (WM) and grey matter (GM). The
clinical utility of CEST-MRF was demonstrated in 4 patients with brain
metastases in comparison to standard clinical imaging sequences. Tumors were
segmented into edema, solid core and necrotic core regions and the CEST-MRF
values compared to the contra-lateral side. $\textbf{Results}$: The DRONE
reconstruction of the digital phantom yielded a normalized RMS error of $\leq$
7% for all parameters. The CEST-MRF parameters were in good agreement with
those from conventional MRF and CEST sequences and previous studies. The mean
CCC for all 6 parameters was 0.98$\pm$0.01 in WM and 0.98$\pm$0.02 in GM. The
CEST-MRF values in nearly all tumor regions were significantly different
(P=0.05) from each other and the contra-lateral side. $\textbf{Conclusion}$:
Combination of EPI readout and deep learning reconstruction enabled fast,
accurate and reproducible CEST-MRF in brain tumors.
